Renaissance Capital logo

DSY News

Renaissance Capital's November IPO Market Update

It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain ...read more

US IPO Weekly Recap: Chinese hotel chain leads a 3 IPO week

Three IPOs and one SPAC began trading this past week, though neither of the scheduled biotechs made it to market as Intensity Therapeutics (INTS) postponed and Acrivon Therapeutics (ACRV) delayed its pricing. One IPO and two...read more

APAC-focused SPAC Plutonian Acquisition prices $50 million IPO

Plutonian Acquisition, a blank check company targeting metaverse tech, tourism, and e-commerce in the APAC region, raised $50 million by offering 5 million units at $10. Each unit consists of one share of common stock, one warrant exercisable at $11.50, and...read more

US IPO Weekly Recap: October IPO market kicks off with a quiet week

The fourth quarter started off with a quiet week, as just one SPAC priced and three small issuers submitted initial filings. Aquaron Acquisition (AQUNU) raised $50 million. Led by CEO and Chair Yi Zhou, co-founding CEO of Ease Consulting and...read more